ArticleiScience2023

The KINETIC phase 2 randomized controlled trial of oral pamapimod-pioglitazone in non-critically ill COVID-19 inpatients.

Thierry Fumeaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.